SEP 8, 2026 · PHASE 4 TRIAL
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
ClinicalTrials.gov
This is a Phase 4 registry record with no reported results; it describes a planned interventional study in active recruitment with estimated enrollment of 200 participants and dual primary outcomes at 12 months.
Reported
Planned enrollment200
Study phasePhase 4
Study duration12 months